Our A2F glycans have been used in FDA and EMEA approved assays since 2002 by pharmaceutical and biotech companies around the world. They are qualified by MS, HPLC, and NMR analysis to meet our rigorous standards of quality and contain no salts or other additives that may interfere with advanced analytical techniques such as mass spectrometry which require the highest levels of purity.
A2F – core-fucosylated disialo biantennary oligosaccharide
A1F – core-fucosylated monosialo biantennary oligosaccharide
NA2F/G2F – core-fucosylated, asialo biantennary oligosaccharide
FA2G1/G1F – core-fucosylated, asialo, monogalactosylated biantennary oligosaccharide
NGA2F/G0F – core-fucosylated, asialo, agalacto biantennary oligosaccharide